LNP Summit 2025: pHLIP Technology for Targeting and Delivery of Gene Therapeutics and Other Therapeutic Payloads
Presented at our LNP Summit Boston – Sept 9, 2025
by Dr. Yana Reshetnyak, CEO & President, pHLIP
Dr. Yana Reshetnyak highlights the groundbreaking potential of pHLIP® (pH‑Low Insertion Peptides) – pH‑sensitive peptides that take advantage of the natural pH differences between healthy and diseased cells. Her talk covers how pHLIP® technology can be used to:
🔹 Target diseased tissues using pH as a biomarker
🔹 Enhance intracellular delivery of gene therapeutics and other drug payloads
🔹 Improve overall delivery selectivity based on physiological pH gradients
Access LNP Video Now
Related Resources
Want to find out more?
Get in touch with our team of experts to explore bespoke end-to-end CDMO support of your complete drug lifecycle
at any scale.